In this respect, our findings are consistent with previous data that SREBP1 is highly expressed in many cancers, including pancreatic cancer, breast cancer, endometrial cancer, prostate, and gastric cancer, and is associated with tumorigenesis [16–20]. Here, SREBF1 is linked to pancreatic neoplasm.